ARCT

Latest SEC Filings & News for ARCT

3 most recent filings and news items mentioning ARCT. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ARCT/news?limit=20"

Pull ARCT filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
OtherJul 2, 2026Positive

Arcturus partners with Thermo Fisher for ARCT-032 manufacturing.

Arcturus Therapeutics entered a strategic collaboration with Thermo Fisher Scientific to manufacture its cystic fibrosis candidate ARCT-032. This partnership accelerates development and secures late-stage manufacturing rights for the partner.

View filing at SEC.gov →
Trading IdeasJul 2, 2026Neutral

This Adobe Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

This Adobe Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

View filing at SEC.gov →
OtherJun 9, 2026Neutral

Arcutis updates non-employee director compensation program effective June 5, 2026

Arcutis Biotherapeutics amended its director compensation program, increasing board retainers to $50,000 annually and initial equity awards to $350,000. The changes affect compensation structure for non-employee directors and committee service.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.